Functional stereotaxy was introduced in the late 1940s to reduce the morbidity of lobotomy in psychiatric disease by using more focal lesions. The advent of neuroleptics led to a drastic decline in psychosurgery for several decades. Functional stereotactic neurosurgery has recently been revitalized, starting with treatment of Parkinson's disease, in which deep brain stimulation (DBS) facilitates reversible focal neuromodulation of altered basal ganglia circuits. DBS is now being extended to treatment of neuropsychiatric conditions such as Gilles de la Tourette syndrome, obsessive-compulsive disorder, depression and addiction. In this review, we discuss the concept that dysfunction of motor, limbic and associative cortico-basal ganglia-thalamocortical loops underlies these various disorders, which might now be amenable to DBS treatment.
Introduction
Human stereotaxy was initially developed to treat psychiatric disease by targeting subcortical structures using circumscribed lesion or focal chronic electrical stimulation [1] [2] [3] [4] [5] [6] . Owing to the demise of psychosurgery following the lobotomy era and abuses of early attempts at deep brain stimulation (DBS) techniques in psychiatric patients [7, 8] , and following the introduction of neuroleptic drugs, functional stereotaxy became limited to the treatment of Parkinson's disease (PD) and other movement disorders (torsion dystonia, action tremor). Such treatment mainly involved lesioning and occasionally DBS [9-12] of various thalamic subnuclei and basal ganglia structures (globus pallidus, subthalamic region).
Neuromodulation using DBS is a reversible method that re-emerged in the 1990s as a more lenient alternative to lesional surgery in advanced PD, especially in bilateral procedures and when targeting the subthalamic nucleus (STN). Choice of the STN as a target for PD arose from studies on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) monkey model of PD, which showed increased neuronal activity in the STN [13] and marked amelioration of parkinsonian features following its lesion [14] . This antiparkinsonian effect could be reproduced with DBS of the STN in this model [15] and later in PD patients [16, 17] . More recently, DBS has been introduced in the field of psychiatry to modulate neuronal activity in the same areas that were targeted for lesioning in the past [18, 19] . Progress in functional neuroimaging and a better understanding of the pathophysiology of psychiatric disorders have contributed to renewed interest in surgical approaches to drug-resistant psychiatric diseases. In this regard, DBS offers several advantages. First, efficacy can be tested in randomized, double-blind, controlled clinical trials [20, 21] . Second, DBS can be switched on and off, so that acute effects can be studied in humans [22, 23] . Third, it can be coupled to functional neuroimaging studies [24, 25] . Finally, implanted electrodes can be used to record neuronal activity within the brain while the patient performs cognitive, emotional or motor tasks [26] . Thus, DBS is not only a therapeutic technique, but also constitutes a powerful tool for the study of brain functions. In this review, we discuss how the observation of non-motor effects of DBS of the STN in both intact animals and parkinsonian patients contributed to the transfer of this technique to the treatment of psychiatric disorders. We propose that focal neuromodulation of corticobasal ganglia (BG)-thalamocortical loops involved in the control of behaviour and emotions might represent a new treatment option in psychiatry paralleling the effect of motor circuit modulation for the treatment of movement disorders.
Surgery for PD: lessons for psychiatry? PD is both a motor and a neuropsychiatric illness [27] . Dopaminergic treatment reverses akinesia and apathy, but excessive and uncontrolled dopaminergic stimulation, as typically occurs in PD patients treated chronically with levodopa, can lead to motor, cognitive and emotional manifestations that are essentially the opposite of the
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